Liukko P, Erkkola R, Bergink E W
Department of Obstetrics and Gynecology, University Central Hospital of Turku, Finland.
Gynecol Obstet Invest. 1988;25(2):118-22. doi: 10.1159/000293757.
Seventeen healthy women received a combination of 0.030 mg of ethinyl estradiol and 0.150 mg of levonorgestrel or a combination of 0.030 mg of ethinyl estradiol and 0.150 mg of desogestrel for 2 years as oral contraception. Serum levels of sex hormone binding globulin, transcortin, ceruloplasmin, and pregnancy-associated protein were measured before contraception, during 3, 6, 12, 18, and 24 months of treatment, and 2 months after stopping the pill. Oral contraception with both preparations induced a similar, significant rise in both ceruloplasmin and pregnancy-associated protein. Sex hormone binding globulin levels rose significantly with the ethinyl estradiol-desogestrel, but not with the ethinyl estradiol-levonorgestrel combination. Transcortin increased with both preparations, more with the ethinyl estradiol-desogestrel combination.
17名健康女性接受了为期2年的口服避孕药治疗,其中一组服用0.030毫克乙炔雌二醇和0.150毫克左炔诺孕酮的组合,另一组服用0.030毫克乙炔雌二醇和0.150毫克去氧孕烯的组合。在避孕前、治疗的第3、6、12、18和24个月以及停药后2个月测量血清性激素结合球蛋白、皮质素转运蛋白、铜蓝蛋白和妊娠相关蛋白水平。两种制剂的口服避孕均导致铜蓝蛋白和妊娠相关蛋白出现相似的显著升高。乙炔雌二醇-去氧孕烯组合使性激素结合球蛋白水平显著升高,而乙炔雌二醇-左炔诺孕酮组合则未使其升高。两种制剂均使皮质素转运蛋白增加,乙炔雌二醇-去氧孕烯组合增加得更多。